Literature DB >> 16379005

Rescue of recombinant Marburg virus from cDNA is dependent on nucleocapsid protein VP30.

Sven Enterlein1, Viktor Volchkov, Michael Weik, Larissa Kolesnikova, Valentina Volchkova, Hans-Dieter Klenk, Elke Mühlberger.   

Abstract

Here we report recovery of infectious Marburg virus (MARV) from a full-length cDNA clone. Compared to the wild-type virus, recombinant MARV showed no difference in terms of morphology of virus particles, intracellular distribution in infected cells, and growth kinetics. The nucleocapsid protein VP30 of MARV and Ebola virus (EBOV) contains a Zn-binding motif which is important for the function of VP30 as a transcriptional activator in EBOV, whereas its role for MARV is unclear. It has been reported previously that MARV VP30 is able to support transcription in an EBOV-specific minigenome system. When the Zn-binding motif was destroyed, MARV VP30 was shown to be inactive in the EBOV system. While it was not possible to rescue recombinant MARV when the VP30 plasmid was omitted from transfection, MARV VP30 with a destroyed Zn-binding motif and EBOV VP30 were able to mediate virus recovery. In contrast, rescue of recombinant EBOV was not supported by EBOV VP30 containing a mutated Zn-binding domain.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16379005      PMCID: PMC1346851          DOI: 10.1128/JVI.80.2.1038-1043.2006

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture.

Authors:  Gabriele Neumann; Heinz Feldmann; Shinji Watanabe; Igor Lukashevich; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

Review 2.  A decade after the generation of a negative-sense RNA virus from cloned cDNA - what have we learned?

Authors:  Gabriele Neumann; Michael A Whitt; Yoshihiro Kawaoka
Journal:  J Gen Virol       Date:  2002-11       Impact factor: 3.891

Review 3.  Reverse genetics of mononegavirales.

Authors:  K K Conzelmann
Journal:  Curr Top Microbiol Immunol       Date:  2004       Impact factor: 4.291

4.  Rescue of Ebola virus from cDNA using heterologous support proteins.

Authors:  Steven Theriault; Allison Groseth; Gabriele Neumann; Yoshihiro Kawaoka; Heinz Feldmann
Journal:  Virus Res       Date:  2004-11       Impact factor: 3.303

5.  Phosphorylation of Marburg virus VP30 at serines 40 and 42 is critical for its interaction with NP inclusions.

Authors:  J Modrof; C Möritz; L Kolesnikova; T Konakova; B Hartlieb; A Randolf; E Mühlberger; S Becker
Journal:  Virology       Date:  2001-08-15       Impact factor: 3.616

6.  The Cys(3)-His(1) motif of the respiratory syncytial virus M2-1 protein is essential for protein function.

Authors:  R W Hardy; G W Wertz
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

7.  Ebola virus transcription activator VP30 is a zinc-binding protein.

Authors:  Jens Modrof; Stephan Becker; Elke Mühlberger
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

8.  Ebola virus VP30-mediated transcription is regulated by RNA secondary structure formation.

Authors:  Michael Weik; Jens Modrof; Hans-Dieter Klenk; Stephan Becker; Elke Mühlberger
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

9.  Human hepatitis delta virus RNA subfragments contain an autocleavage activity.

Authors:  H N Wu; Y J Lin; F P Lin; S Makino; M F Chang; M M Lai
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

10.  Infectious defective interfering particles of VSV from transcripts of a cDNA clone.

Authors:  A K Pattnaik; L A Ball; A W LeGrone; G W Wertz
Journal:  Cell       Date:  1992-06-12       Impact factor: 41.582

View more
  36 in total

1.  Evaluation of perceived threat differences posed by filovirus variants.

Authors:  Jens H Kuhn; Lori E Dodd; Victoria Wahl-Jensen; Sheli R Radoshitzky; Sina Bavari; Peter B Jahrling
Journal:  Biosecur Bioterror       Date:  2011-11-09

2.  Recombinant Marburg virus expressing EGFP allows rapid screening of virus growth and real-time visualization of virus spread.

Authors:  Kristina Maria Schmidt; Michael Schümann; Judith Olejnik; Verena Krähling; Elke Mühlberger
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

3.  Basic residues within the ebolavirus VP35 protein are required for its viral polymerase cofactor function.

Authors:  Kathleen C Prins; Jennifer M Binning; Reed S Shabman; Daisy W Leung; Gaya K Amarasinghe; Christopher F Basler
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

Review 4.  Nonsegmented negative-strand viruses as vaccine vectors.

Authors:  Alexander Bukreyev; Mario H Skiadopoulos; Brian R Murphy; Peter L Collins
Journal:  J Virol       Date:  2006-11       Impact factor: 5.103

5.  Key genomic changes necessary for an in vivo lethal mouse marburgvirus variant selection process.

Authors:  Loreen L Lofts; Jay B Wells; Sina Bavari; Kelly L Warfield
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

6.  Establishment and characterization of plasmid-driven minigenome rescue systems for Nipah virus: RNA polymerase I- and T7-catalyzed generation of functional paramyxoviral RNA.

Authors:  Alexander Freiberg; Lhia Krista Dolores; Sven Enterlein; Ramon Flick
Journal:  Virology       Date:  2007-09-27       Impact factor: 3.616

7.  The Ebola virus ribonucleoprotein complex: a novel VP30-L interaction identified.

Authors:  A Groseth; J E Charton; M Sauerborn; F Feldmann; S M Jones; T Hoenen; H Feldmann
Journal:  Virus Res       Date:  2008-12-16       Impact factor: 3.303

8.  Filovirus replication and transcription.

Authors:  Elke Mühlberger
Journal:  Future Virol       Date:  2007-03       Impact factor: 1.831

9.  The L-VP35 and L-L interaction domains reside in the amino terminus of the Ebola virus L protein and are potential targets for antivirals.

Authors:  Martina Trunschke; Dominik Conrad; Sven Enterlein; Judith Olejnik; Kristina Brauburger; Elke Mühlberger
Journal:  Virology       Date:  2013-04-11       Impact factor: 3.616

10.  Establishment of fruit bat cells (Rousettus aegyptiacus) as a model system for the investigation of filoviral infection.

Authors:  Verena Krähling; Olga Dolnik; Larissa Kolesnikova; Jonas Schmidt-Chanasit; Ingo Jordan; Volker Sandig; Stephan Günther; Stephan Becker
Journal:  PLoS Negl Trop Dis       Date:  2010-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.